Search Results 101-110 of 16148 for chemoprevention
Patients who received tamoxifen or raloxifene for purposes of chemoprevention (e.g., Breast Cancer Prevention Trial) or for other indications (including ...
MemberChemoprevention Subcommittee, Cancer Control Research Committee, Southwest Oncology Group. 1998 - present. FellowAmerican College of Physicians. 1997 ...
See also. Atypical hyperplasia of the breast · Breast cancer · Breast Cancer · Breast cancer chemoprevention · Breast Cancer Education Tool · Common questions ...
No concurrent tamoxifen or other SERMs; Prior tamoxifen or other selective estrogen receptor modulator (SERM) for chemoprevention (e.g., Breast Cancer ...
... chemopreventive regimens. Tucatinib, Trastuzumab, Ramucirumab, and Paclitaxel Versus Paclitaxel and Ramucirumab in Previously Treated HER2+ Gastroesophageal ...
The first chemoprevention phase 0 exploratory pharmacokinetic clinical trial (first-in-man) of the Akt inhibitor SR13668 to establish a formulation with the ...
NOTE: Prior use of tamoxifen for chemoprevention is allowed but must be discontinued at study entry. Similarly, prior raloxifene use is allowed but must be ...
Prior tamoxifen or other selective estrogen receptor modulator (SERM) for chemoprevention (e.g., Breast Cancer Prevention Trial) or for other indications (e.g., ...
Breast cancer chemoprevention · Breast Cancer Education Tool · Common questions about breast cancer treatment · Breast cancer prevention · Infographic: Breast ...
Mayo Clinic does not endorse companies or products. Advertising revenue supports our not-for-profit mission.
Check out these best-sellers and special offers on books and newsletters from Mayo Clinic Press.
Make your tax-deductible gift and be a part of the cutting-edge research and care that's changing medicine.